Company page

Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd. (ticker: PAR) is a public company based in Australia, focused on developing innovative therapies for various medical conditions. With a market capitalization of approximately AUD 74 million, Paradigm is dedicated to advancing its research and product pipeline. The company aims to address unmet medical needs through its commitment to biopharmaceutical development.